Intronn Overview

  • Founded
  • 1988
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 11
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 5

Intronn General Information

Description

Developer of spliceosome-mediated RNA trans-splicing (SMaRT) technology. The company has produced a series of PTMs capable of base-pairing to and trans-splicing with disease associated pre-mRNA targets.

Contact Information

Website
www.intronn.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Virxsys
Primary Office
  • 910 Clopper Road
  • South Building, Suite 210
  • Gaithersburg, MD 20878
  • United States
+1 (240) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intronn Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Intronn‘s full profile, request access.

Request a free trial

Intronn Executive Team (1)

Name Title Board Seat Contact Info
Gerard McGarrity President & Chief Executive Officer
To view Intronn’s complete executive team members history, request access »

Intronn Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intronn Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intronn‘s full profile, request access.

Request a free trial